Carregant...
Breast Tenderness and Breast Cancer Risk in the Estrogen plus Progestin and Estrogen-Alone Women’s Health Initiative Clinical Trials
BACKGROUND: The associations between breast tenderness during use of conjugated equine estrogen (CEE) therapy with or without medroxyprogesterone (MPA) therapy and subsequent breast cancer risk are unknown. METHODS: We analyzed data from the Women’s Health Initiative Estrogen plus Progestin (N = 16,...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3697872/ https://ncbi.nlm.nih.gov/pubmed/22042371 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-011-1848-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|